Skip to content

Supplement comparison

Bacopa Monnieri vs Ginkgo Biloba

Short answer: We found no study on file that gave Bacopa Monnieri and Ginkgo Biloba as separate treatments in the same trial, so this is not a head-to-head result: each grade below was set for that supplement on its own. Both have graded results for 3 of the same conditions: memory improvement, Age-Associated memory impairment and cognitive decline (AAMCD) and cognitive improvement. Bacopa Monnieri's top grade for an improvement there is B (memory improvement); Ginkgo Biloba's top grade for an improvement there is C (cognitive improvement). A grade rates how strong the evidence is, not how large the effect is, so it does not say which one works better.

Grades and study counts are computed from the same rows as the Bacopa Monnieri and Ginkgo Biloba pages. This page compares evidence only; it sells nothing.

The evidence side by side

  • Strong
  • Moderate
  • Limited
  • Very limited

3 conditions where both have graded results with linked studies. Each grade was set for that supplement on its own: a grade on the left was not tested against the grade on the right.

Memory Improvement

Memory Enhancement & Support supplement stack: doses and evidence

OutcomeBacopa MonnieriGinkgo Biloba
Memory
Improves · 6 studies

Studied as: Not listed: ask a clinician

Not graded for this
CognitionNot graded for this
Mixed effect · 3 studies

Age-Associated Memory Impairment and Cognitive Decline (AAMCD)

Age-Related Cognitive Decline (ARCD) Support supplement stack: doses and evidence

OutcomeBacopa MonnieriGinkgo Biloba
Attention
Improves · 3 studies
Not graded for this
CognitionNot graded for this
No effect · 3 studies

Studied as: Standardised ginkgo leaf extract (EGb 761 type) taken daily for weeks to 6 years by older adults with normal cognition or mild impairment

Cognitive Improvement

Cognitive Improvement supplement stack: doses and evidence

OutcomeBacopa MonnieriGinkgo Biloba
Alzheimer's Disease Symptoms
No clear effect · 1 study
Improves · 3 studies

Studied as: Not listed: ask a clinician

3 graded results in conditions both have been studied for are not set side by side here: they came from studies in pregnancy, children, teenagers, cancer or kidney disease (dialysis included), from animal or lab work only, or from studies that did not test the sport a condition is named for, or they measure a stress hormone rather than a health result. Each supplement's page lists them.

Safety and interactions

For each supplement, our library safety line where we have one, and every reviewed safety item from its page, in full.

Bacopa Monnieri

  • Bacopa has only minor and usually short-lived side effects which may include abdominal pain, nausea, diarrhea, flatulence, dry mouth, headache, dizziness, insomnia, and rash. Importantly, despite widespread use, bacopa has not been implicated in cases of clinically apparent liver disease.
  • Gut upset is the side effect seen most in trials: bacopa caused more frequent stools, abdominal cramps and nausea than placebo in older adults, and stomach upset was the main complaint in a second trial; in a 2025 trial, side effects, mostly digestive complaints and headaches, were reported more often on bacopa. (PMID 20590480; PMID 18611150; PMID 41091332)
  • In lab tests, bacopa extract blocked several liver and gut enzymes (CYP3A4, CYP2C9, CYP2C19, CYP1A2) that clear many prescription drugs, and one case report linked a bacopa product to suspected cholinergic toxicity (sweating, nausea, fast heart rate) in a woman taking cevimeline. Ask a pharmacist before combining it with regular medicines. (PMID 24566323; PMID 35765109)
  • Worsening memory, confusion or personality change needs a medical assessment rather than a herbal trial; bacopa has not been shown to slow Alzheimer disease and should not replace prescribed dementia treatment. (PMID 35612544)
  • Bacopa has not been tested for safety in pregnancy or breastfeeding, so avoid it at those times unless a doctor advises otherwise.

Everything on Bacopa Monnieri

Ginkgo Biloba

  • Ginkgo and bleeding: in an observational study of US veterans' health records, published as a conference paper, people taking warfarin who also took ginkgo had more bleeding events (hazard ratio 1.38). Clotting tests did not change in 18 randomised trials, but those were laboratory tests, not bleeding events. A systematic review found 15 published case reports of bleeding in people using ginkgo, including 8 episodes of intracranial bleeding (bleeding inside the skull), and concluded that they suggest 'a possible causal association between using ginkgo and bleeding events'. (PMID 26958257; PMID 21923430; PMID 16050865)
  • Bleeding: in a large US veterans' health-record study, people taking the blood thinner warfarin who also took ginkgo had a higher risk of a bleeding event (hazard ratio 1.38). A meta-analysis of blood clotting tests, not bleeding events, found no change with standardized ginkgo extract, and the 2022 tinnitus review found little to no difference in bleeding or seizures in 4 trials (low certainty). A review of 15 published case reports also described bleeding in people taking ginkgo, 8 of them inside the skull; most had other bleeding risks, but the authors judged a causal link possible. If you take warfarin, aspirin, clopidogrel or another blood thinner, or have surgery planned, ask your doctor before using ginkgo. (PMID 21923430; PMID 36383762; PMID 16050865; PMID 26958257)
  • Side effects: in the Cochrane review, people with dementia or mild cognitive impairment had about the same rate of adverse events on ginkgo as on placebo for up to 12 months, but one 3-month study in people with memory complaints suggested more adverse events with ginkgo. (PMID 41641880)
  • Ginkgo seeds are toxic in large amounts: a case report describes vomiting and a seizure in a young child after eating many seeds. Leaf extract has also been linked to seizures: two people with well-controlled epilepsy had repeated seizures within 2 weeks of starting it, so people with epilepsy should ask their doctor first. In 2-year US government tests in animals, high doses of ginkgo leaf extract raised liver tumours in mice and caused liver and thyroid changes in rats and mice; whether this applies to people is not known. (PMID 11826216; PMID 11742783; PMID 23652021)
  • New or worsening memory loss needs a medical assessment rather than self-treatment. Call emergency services for sudden confusion, weakness or numbness on one side, slurred speech or a drooping face, which can be signs of a stroke.

Results on the Ginkgo Biloba page where it made a measure worse, or that record side effects in trials:

Everything on Ginkgo Biloba

Questions

How do Bacopa Monnieri and Ginkgo Biloba compare?

We found no study on file that gave Bacopa Monnieri and Ginkgo Biloba as separate treatments in the same trial, so this is not a head-to-head result: each grade below was set for that supplement on its own. Both have graded results for 3 of the same conditions: memory improvement, Age-Associated memory impairment and cognitive decline (AAMCD) and cognitive improvement. Bacopa Monnieri's top grade for an improvement there is B (memory improvement); Ginkgo Biloba's top grade for an improvement there is C (cognitive improvement). A grade rates how strong the evidence is, not how large the effect is, so it does not say which one works better.

What have both Bacopa Monnieri and Ginkgo Biloba been studied for?

In our database both have graded results for memory improvement, Age-Associated memory impairment and cognitive decline (AAMCD) and cognitive improvement. Each supplement's own page lists every condition it has been studied for.

Which outcomes were measured for both Bacopa Monnieri and Ginkgo Biloba?

Cognitive Improvement: alzheimer's disease symptoms. Each grade was set for that supplement on its own, so the grades sit side by side but do not compare the two in one trial.

Are Bacopa Monnieri and Ginkgo Biloba safe?

Each has its own cautions, listed in full on this page under "Safety and interactions" and on each supplement's page. Ask your clinician before starting either if you take medicines, are pregnant or have a long-term condition.